Trividia Health Debuts Innovative 5-Bevel Pen Needles in UK

Trividia Health has expanded its international footprint by launching the TRUEplus 5-Bevel Pen Needles in the UK, marking the product’s debut outside of the United States. The needles, designed for enhanced comfort and cost-effectiveness, bring diverse options to healthcare professionals managing diabetic care. This significant move could greatly impact the diabetes management market by improving patient experience and adherence.

Trividia Health’s entry into the UK market with their innovative 5-bevel pen needle design offers an alternative to traditional 3-bevel needles. Engineered to enhance the injection experience and boost compliance, these needles are available in various sizes, including 31 Gauge 5mm, 6mm, and 8mm, as well as 32 Gauge 4mm. The introduction of these needles underscores Trividia’s commitment to providing accessible and affordable diabetes management solutions. As the US-based parent company of Trividia Health UK, Trividia is well-positioned to make a significant impact on the market, offering a valuable option for cost-conscious healthcare providers and patients.